Entering text into the input field will update the search result below

Investing In Health Food Sales Earnings Growth - HAIN

Sep. 12, 2016 9:02 PM ETHAIN, JJSF, TSN, PF, GIS, HRL, LANC, MKC, BGS, CVGW, SJM
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
Hain Celestial Health Food

Hain Celestial Is a Natural Investment Choice Again By The Street

The organic food company's risk-reward ratio is now more positive.

Shares of organic and natural products distributor Hain Celestial (HAIN) has gotten punished over the past month, falling more than 31% because the company last month delayed its annual filing and issued a weak outlook.

The reason for the delay? The Lake Success, N.Y.-based company said it was investigating certain revenue arrangements with distributors. During the fourth quarter, Hain said it identified "concessions that were granted to certain distributors in the United States." As a result, Hain wants more time to evaluate whether it correctly accounted for those revenue and said it wants to assess its internal controls over financial reporting.

While the accounting issues are worrisome, the 30% plunge the stock has taken seems overdone. Purely from a risk-reward perspective, now's the time buy HAIN and hold for the next 12 to 18 months. Despite the massive drop, Hain Celestial shares, at around $36, are trading some 8% above its 52-week low of $33.12, which suggests the stock might have already bottomed.

The shares should bounce back once the accounting issues are cleared up. The accounting issues aside, Hain still has a strong business and remains a solid play consumers driving towards healthier living. Thanks to its strategic M&A track record, Hain has built itself into a leading organic-food position and should command a premium to its peers.

With the 40% decline from its 52-week high of $59.74, HAIN is now priced at just 16 times fiscal 2017 estimates of $2.15 per share. This is about four points below where the organic category has traded. This means, when applying a 20-point multiple to the 2017 estimates of $2.15, it yields a stock price of around $43, or 20% premium above Hain's closing price on Friday of $35.77.

It's likely for this reason, HAIN has a consensus buy rating and an average analysts 12-month price target of $44.50. Given these factors, including the likelihood that Hain may find nothing from its internal investigation, the risk-reward ratio has turned positive and you should be a buyer at current levels.

Investment Advisory

Invest2Success Investment Advisory Stock Picks
Free Trial - Receive daily low-risk high-reward SP500 NYSE Nasdaq buy-long and short-sell stock picks that are experiencing strong increasing and decreasing earnings, that include buy sell entry, stop-loss, take profit area price targets, and trade management information to your email inbox.

Candle Charting Intensive Training

Steve Nisons Candlestick Charting Intensive Training and Software
for Profitably Trading Stocks Forex Futures Commodities

Van Tharp Institute
Van Tharp Institute

Dr. Van Tharp Trading Education Institute
Investing Trading Home Study Programs & Live Seminars Workshops

MTPredictor Professional Trading Software

MTPredictor - Free Demo
Elliott Wave and Fibonacci Trading Software

Track n Trade Trading Software

TracknTrade CandleStick Trading Software with Auto-Recognition Plug-in

Money Tools

The Top Technical Analysis Trading Tools

Live Trading Seminars

Stock Option Forex Futures Training Seminars Webinars Workshops
Click Here For The Complete 2016 Schedule

Professional investors traders teaching successful low-risk high-reward
trade strategies. Power profit secrets for stocks, options, forex, futures
investing trading success. Or avail of Home Study Courses and or
Trading Softwares available to improve your investment returns.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You